Statement Of Financial Position [Abstract]

Xbrane Biopharma - Filing #679208

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	—	—	32 537 SEK	34 830 SEK	—	—	—	—	—	—	—	—	—
Right-of-use assets	—	—	—	—	55 663 SEK	36 220 SEK	—	—	—	—	—	—	—	—	—
Goodwill	—	—	—	—	– SEK	– SEK	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	—	—	99 670 SEK	101 995 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	—	65 402 SEK	193 994 SEK	—	—	—	—	295 180 SEK	—	—	—	—
Assets	—	—	—	—	653 508 SEK	690 515 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	—	6 683 SEK	6 166 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	—	—	—	—	1 273 999 SEK	885 827 SEK	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	—	—	—	—	171 335 SEK	424 888 SEK	—	—	—	—	—	—	—	—	—
Non-controlling interests	—	—	—	—	– SEK	– SEK	—	—	—	—	—	—	—	—	—
Equity	6 683 SEK	10 121 SEK	1 273 999 SEK	1 428 530 SEK	171 335 SEK	424 888 SEK	885 827 SEK	6 166 SEK	10 322 SEK	1 294 227 SEK	431 741 SEK	713 313 SEK	1 134 276 SEK	5 165 SEK	5 614 SEK
Liabilities [abstract]
Liabilities included in disposal groups classified as held for sale	—	—	—	—	606,000 SEK	937,000 SEK	—	—	—	—	—	—	—	—	—
Liabilities	—	—	—	—	482 173 SEK	265 626 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities	—	—	—	—	653 508 SEK	690 515 SEK	—	—	—	—	—	—	—	—	—